POST-CABGDM: Empagliflozin in Perioperative CABG
NCT04523064
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
155
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Coronary Artery Disease
Coronary Artery Bypass Surgery
Acute Kidney Injury
Interventions
DRUG:
Empagliflozin 25 MG
Sponsor
University of Sao Paulo General Hospital